Viewing Study NCT00447356


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-01-02 @ 7:52 AM
Study NCT ID: NCT00447356
Status: WITHDRAWN
Last Update Posted: 2013-05-13
First Post: 2007-03-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma
Sponsor: Hackensack Meridian Health
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma (Skin) View
Keywords: